The use of biologics targeting autoimmune responses and inflammatory pathways has revolutionized the management of chronic conditions such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. This approach has also extended to the field of nephrology, where we are witnessing an innovation of therapeutic paradigms for immune-mediated pathologies, thanks to the advent of these drugs. These advancements have shown particular promise in glomerular diseases and kidney transplantation.
This Research Topic aims to delve into the current advancements in the use of biologics in renal diseases. The primary focus will be on assessing the mechanisms of action and the clinical effects of biologics on primary and secondary glomerular diseases, such as idiopathic membranous nephropathy, IgA nephropathy, C3 nephropathy, lupus nephritis, anti-neutrophil cytoplasmic antibody-associated glomerulonephritis, and anti-glomerular basement membrane glomerulonephritis. Furthermore, the research will shed light on novel applications of biologics in kidney transplantation, offering insights into improving graft survival, reducing rejection rates, and optimizing post-transplant outcomes.
The scope of this Research Topic is to provide a comprehensive overview of the state-of-the-art utilization of biologics in renal diseases, covering recent advancements and potential future developments. We welcome the submissions of systematic reviews, reviews, mini reviews, original research articles reporting the results of retrospective or prospective studies, as well as case reports.
The use of biologics targeting autoimmune responses and inflammatory pathways has revolutionized the management of chronic conditions such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. This approach has also extended to the field of nephrology, where we are witnessing an innovation of therapeutic paradigms for immune-mediated pathologies, thanks to the advent of these drugs. These advancements have shown particular promise in glomerular diseases and kidney transplantation.
This Research Topic aims to delve into the current advancements in the use of biologics in renal diseases. The primary focus will be on assessing the mechanisms of action and the clinical effects of biologics on primary and secondary glomerular diseases, such as idiopathic membranous nephropathy, IgA nephropathy, C3 nephropathy, lupus nephritis, anti-neutrophil cytoplasmic antibody-associated glomerulonephritis, and anti-glomerular basement membrane glomerulonephritis. Furthermore, the research will shed light on novel applications of biologics in kidney transplantation, offering insights into improving graft survival, reducing rejection rates, and optimizing post-transplant outcomes.
The scope of this Research Topic is to provide a comprehensive overview of the state-of-the-art utilization of biologics in renal diseases, covering recent advancements and potential future developments. We welcome the submissions of systematic reviews, reviews, mini reviews, original research articles reporting the results of retrospective or prospective studies, as well as case reports.